Cargando…

Towards a Stepped Care Model for Managing Fear of Cancer Recurrence or Progression in Cancer Survivors

BACKGROUND: Fear of cancer recurrence or progression (FCR) is common amongst cancer survivors and an important minority develop clinically significant levels of FCR. However, it is unclear how current clinical services might best support the growing numbers of cancer survivors. PURPOSE: The aim of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Pradhan, Poorva, Sharpe, Louise, Menzies, Rachel E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645945/
https://www.ncbi.nlm.nih.gov/pubmed/34880676
http://dx.doi.org/10.2147/CMAR.S294114
_version_ 1784610418384175104
author Pradhan, Poorva
Sharpe, Louise
Menzies, Rachel E
author_facet Pradhan, Poorva
Sharpe, Louise
Menzies, Rachel E
author_sort Pradhan, Poorva
collection PubMed
description BACKGROUND: Fear of cancer recurrence or progression (FCR) is common amongst cancer survivors and an important minority develop clinically significant levels of FCR. However, it is unclear how current clinical services might best support the growing numbers of cancer survivors. PURPOSE: The aim of this study is to develop recommendations for future research in the management of FCR and propose a model of care to help manage FCR in the growing population of cancer survivors. METHODS: This is a narrative review and synthesis of empirical research relevant to managing FCR. We reviewed meta-analyses, systematic reviews and individual studies that had investigated interventions for FCR. RESULTS: A recent, well-conducted meta-analysis confirmed a range of moderately effective treatments for FCR. However, many survivors continued to experience clinical levels of FCR after treatment, indicating a clear need to improve the gold standard treatments. Accessibility of interventions is arguably a greater concern. The majority of FCR treatments require face-to-face therapy, with highly skilled psycho-oncologists to produce moderate changes in FCR. With increasing numbers of cancer survivors, we need to consider how to meet the unmet need of cancer survivors in relation to FCR. Although there have been attempts to develop minimal interventions, these are not yet sufficiently well supported to warrant implementation. Attempts to help clinicians to provide information which might prevent the development of clinically significant FCR have shown some early promise, but research is needed to confirm efficacy. CONCLUSION: The next decade of research needs to focus on developing preventative approaches for FCR, and minimal interventions for those with mild-to-moderate symptoms. When evidence-based approaches to prevent FCR or manage moderate levels of FCR are available, stepped care approaches that could meet the needs of survivors could be implemented. However, we also need to improve existing interventions for severe FCR.
format Online
Article
Text
id pubmed-8645945
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-86459452021-12-07 Towards a Stepped Care Model for Managing Fear of Cancer Recurrence or Progression in Cancer Survivors Pradhan, Poorva Sharpe, Louise Menzies, Rachel E Cancer Manag Res Review BACKGROUND: Fear of cancer recurrence or progression (FCR) is common amongst cancer survivors and an important minority develop clinically significant levels of FCR. However, it is unclear how current clinical services might best support the growing numbers of cancer survivors. PURPOSE: The aim of this study is to develop recommendations for future research in the management of FCR and propose a model of care to help manage FCR in the growing population of cancer survivors. METHODS: This is a narrative review and synthesis of empirical research relevant to managing FCR. We reviewed meta-analyses, systematic reviews and individual studies that had investigated interventions for FCR. RESULTS: A recent, well-conducted meta-analysis confirmed a range of moderately effective treatments for FCR. However, many survivors continued to experience clinical levels of FCR after treatment, indicating a clear need to improve the gold standard treatments. Accessibility of interventions is arguably a greater concern. The majority of FCR treatments require face-to-face therapy, with highly skilled psycho-oncologists to produce moderate changes in FCR. With increasing numbers of cancer survivors, we need to consider how to meet the unmet need of cancer survivors in relation to FCR. Although there have been attempts to develop minimal interventions, these are not yet sufficiently well supported to warrant implementation. Attempts to help clinicians to provide information which might prevent the development of clinically significant FCR have shown some early promise, but research is needed to confirm efficacy. CONCLUSION: The next decade of research needs to focus on developing preventative approaches for FCR, and minimal interventions for those with mild-to-moderate symptoms. When evidence-based approaches to prevent FCR or manage moderate levels of FCR are available, stepped care approaches that could meet the needs of survivors could be implemented. However, we also need to improve existing interventions for severe FCR. Dove 2021-12-01 /pmc/articles/PMC8645945/ /pubmed/34880676 http://dx.doi.org/10.2147/CMAR.S294114 Text en © 2021 Pradhan et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Pradhan, Poorva
Sharpe, Louise
Menzies, Rachel E
Towards a Stepped Care Model for Managing Fear of Cancer Recurrence or Progression in Cancer Survivors
title Towards a Stepped Care Model for Managing Fear of Cancer Recurrence or Progression in Cancer Survivors
title_full Towards a Stepped Care Model for Managing Fear of Cancer Recurrence or Progression in Cancer Survivors
title_fullStr Towards a Stepped Care Model for Managing Fear of Cancer Recurrence or Progression in Cancer Survivors
title_full_unstemmed Towards a Stepped Care Model for Managing Fear of Cancer Recurrence or Progression in Cancer Survivors
title_short Towards a Stepped Care Model for Managing Fear of Cancer Recurrence or Progression in Cancer Survivors
title_sort towards a stepped care model for managing fear of cancer recurrence or progression in cancer survivors
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645945/
https://www.ncbi.nlm.nih.gov/pubmed/34880676
http://dx.doi.org/10.2147/CMAR.S294114
work_keys_str_mv AT pradhanpoorva towardsasteppedcaremodelformanagingfearofcancerrecurrenceorprogressionincancersurvivors
AT sharpelouise towardsasteppedcaremodelformanagingfearofcancerrecurrenceorprogressionincancersurvivors
AT menziesrachele towardsasteppedcaremodelformanagingfearofcancerrecurrenceorprogressionincancersurvivors